Ferdinand M. van’t Hooft

6.5k total citations
19 papers, 748 citations indexed

About

Ferdinand M. van’t Hooft is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ferdinand M. van’t Hooft has authored 19 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ferdinand M. van’t Hooft's work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Ferdinand M. van’t Hooft is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Ferdinand M. van’t Hooft collaborates with scholars based in Sweden, Netherlands and United States. Ferdinand M. van’t Hooft's co-authors include Anders Hamsten, Per Eriksson, Tiina Skoog, Bengt Kallin, Susanna Boquist, Jan Nilsson, Stefan Jovinge, Arie van Tol, Mai-Lis Hellénius and Teus van Gent and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ferdinand M. van’t Hooft

19 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ferdinand M. van’t Hooft Sweden	12	304	180	163	136	123	19	748
Adrian Serone United States	12	217 0.7×	152 0.8×	153 0.9×	84 0.6×	173 1.4×	29	700
Concetta Amore Italy	17	125 0.4×	119 0.7×	116 0.7×	129 0.9×	83 0.7×	30	919
Albert Császár Hungary	17	268 0.9×	261 1.4×	300 1.8×	144 1.1×	233 1.9×	50	1.1k
Takuji Hayashi Japan	23	391 1.3×	246 1.4×	148 0.9×	193 1.4×	128 1.0×	64	1.5k
L Romics Hungary	13	198 0.7×	147 0.8×	151 0.9×	73 0.5×	125 1.0×	42	587
Delia Susan‐Resiga Canada	17	260 0.9×	292 1.6×	118 0.7×	70 0.5×	81 0.7×	30	827
D Schönitzer Austria	21	300 1.0×	203 1.1×	369 2.3×	145 1.1×	127 1.0×	46	1.5k
Federica Basso United States	13	545 1.8×	314 1.7×	177 1.1×	179 1.3×	156 1.3×	20	941
Z Yasruel Canada	9	244 0.8×	196 1.1×	134 0.8×	104 0.8×	116 0.9×	9	885
Takayuki Iwaki Japan	18	92 0.3×	202 1.1×	183 1.1×	111 0.8×	60 0.5×	44	1.1k

Countries citing papers authored by Ferdinand M. van’t Hooft

Since Specialization

Citations

This map shows the geographic impact of Ferdinand M. van’t Hooft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinand M. van’t Hooft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinand M. van’t Hooft more than expected).

Fields of papers citing papers by Ferdinand M. van’t Hooft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdinand M. van’t Hooft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinand M. van’t Hooft. The network helps show where Ferdinand M. van’t Hooft may publish in the future.

Co-authorship network of co-authors of Ferdinand M. van’t Hooft

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdinand M. van’t Hooft. A scholar is included among the top collaborators of Ferdinand M. van’t Hooft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdinand M. van’t Hooft. Ferdinand M. van’t Hooft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Pott, Janne, Jesper R. Gådin, Elizabeth Theusch, et al.. (2021). Meta-GWAS of PCSK9 levels detects two novel loci atAPOBandTM6SF2. Human Molecular Genetics. 31(6). 999–1011. 13 indexed citations

Taxiarchis, Apostolos, Hovsep Mahdessian, Angela Silveira, Rachel M. Fisher, & Ferdinand M. van’t Hooft. (2019). PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells. Journal of Lipid Research. 60(6). 1069–1077. 16 indexed citations

Leander, Karin, Anders Mälarstig, Ferdinand M. van’t Hooft, et al.. (2016). Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors. Circulation. 133(13). 1230–1239. 162 indexed citations

Gådin, Jesper R., Ferdinand M. van’t Hooft, Per Eriksson, & Lasse Folkersen. (2015). AllelicImbalance: an R/ bioconductor package for detecting, managing, and visualizing allele expression imbalance data from RNA sequencing. BMC Bioinformatics. 16(1). 194–194. 10 indexed citations

Iglesias, María Jesús, Angela Silveira, Jesper Tegnér, et al.. (2010). DGAT1 Participates in the Effect of HNF4A on Hepatic Secretion of Triglyceride-Rich Lipoproteins. Arteriosclerosis Thrombosis and Vascular Biology. 30(5). 962–967. 15 indexed citations

Popov, Sergej, Ekaterina Chernogubova, Mai-Lis Hellénius, et al.. (2008). Insulin-Induced Gene 2 Involvement in Human Adipocyte Metabolism and Body Weight Regulation. The Journal of Clinical Endocrinology & Metabolism. 93(5). 1995–2001. 40 indexed citations

Abrahamsson, Anna, Ulf Gustafsson, Olle Muhrbeck, et al.. (2005). Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration. Atherosclerosis. 182(1). 37–45. 17 indexed citations

Skoog, Tiina, Ferdinand M. van’t Hooft, Bengt Kallin, et al.. (1999). A Common Functional Polymorphism (C->A Substitution at Position -863) in the Promoter Region of the Tumour Necrosis Factor- (TNF- ) Gene Associated With Reduced Circulating Levels of TNF- . Human Molecular Genetics. 8(8). 1443–1449. 290 indexed citations

Skoog, Tiina, Ferdinand M. van’t Hooft, Bengt Kallin, et al.. (1999). A common polymorphism in the promoter region of TNF-alpha gene determining the serum TNF-alpha concentration. Atherosclerosis. 144. 121–121. 1 indexed citations

10.

Zhao, Shui‐Ping, et al.. (1994). Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil. The American Journal of Medicine. 96(1). 49–56. 10 indexed citations

11.

Zhao, Shui‐Ping, Arn M. J. M. van den Maagdenberg, Ferdinand M. van’t Hooft, et al.. (1994). Lipoprotein Profiles in a Family with Two Mutants of Apolipoprotein E: Possible Association with Hypertriglyceridaemia but Not with Dysbetalipoproteinaemia. Clinical Science. 86(3). 323–329. 6 indexed citations

12.

Hooft, Ferdinand M. van’t, Teus van Gent, & Arie van Tol. (1987). Effect of 17α-ethinylestradiol on the catabolism of high-density lipoprotein apolipoprotein A-I in the rat. Atherosclerosis. 67(1). 23–31. 4 indexed citations

13.

Tol, Arie van, Ferdinand M. van’t Hooft, Teus van Gent, & Geesje M. Dallinga‐Thie. (1987). HDL Subfractions, HDL Receptors and HDL Turnover. Advances in experimental medicine and biology. 210. 15–21. 3 indexed citations

14.

Dallinga‐Thie, Geesje M., Arie van Tol, Ferdinand M. van’t Hooft, & Pieter H.E. Groot. (1986). Distribution of apolipoproteins A-I and A-IV among lipoprotein classes in rat mesenteric lymph, fractionated by molecular sieve chromatography. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 876(1). 108–115. 13 indexed citations

15.

Dallinga‐Thie, Geesje M., Ferdinand M. van’t Hooft, & Arie van Tol. (1986). Comparison of the metabolic behavior of rat apolipoproteins A-I AND A-IV, isolated from both lymph chylomicrons and serum high density lipoproteins. International Journal of Biochemistry. 18(4). 383–388. 1 indexed citations

16.

Hooft, Ferdinand M. van’t & A. van Tol. (1985). The sites of degradation of rat high-density-lipoprotein apolipoprotein E specifically labelled with O-(4-diazo-3-[125I]iodobenzoyl)sucrose. Biochemical Journal. 226(3). 715–721. 12 indexed citations

17.

Hooft, Ferdinand M. van’t, Geesje M. Dallinga‐Thie, & Arie van Tol. (1985). Leupeptin as a tool for the detection of the sites of catabolism of rat high-density lipoprotein apolipoproteins A-I and E. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 834(1). 75–84. 18 indexed citations

18.

Hooft, Ferdinand M. van’t, D A Hardman, John P. Kane, & Richard J. Havel. (1982). Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins.. Proceedings of the National Academy of Sciences. 79(1). 179–182. 62 indexed citations

19.

Hooft, Ferdinand M. van’t, Teus van Gent, & Arie van Tol. (1981). Turnover and uptake by organs of radioactive serum high-density lipoprotein cholesteryl esters and phospholipids in the rat in vivo. Biochemical Journal. 196(3). 877–885. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact